Patents Assigned to Eccogene Inc.
  • Thyroid hormone receptor agonists and use thereof
    Patent number: 12291518
    Abstract: The application relates to a compound of Formula (I?) or (I): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of thyroid hormone receptors, a pharmaceutical composition comprising a compound of Formula (I?) or (I), and a method of treating or preventing a disease or disorder regulated by thyroid hormone.
    Type: Grant
    Filed: August 11, 2023
    Date of Patent: May 6, 2025
    Assignee: Eccogene Inc.
    Inventors: Jingye Zhou, Jiuxiang Zhu, Mingwei Zheng
  • Substituted imidazoles as GLP-1 receptor agonists
    Patent number: 12037339
    Abstract: The application relates to a compound of Formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of GLP-1 receptor, a pharmaceutical composition comprising a compound of Formula (I), and a method of treating or preventing a disease in which GLP-1 receptor plays a role.
    Type: Grant
    Filed: July 20, 2021
    Date of Patent: July 16, 2024
    Assignee: Eccogene Inc.
    Inventors: Zaifang Ren, Xuefeng Sun, Jingye Zhou